Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
3,895 studies for “multiple sclerosis”
Sponsor: TG Therapeutics, Inc.
Multiple Sclerosis
Bosnia and Herzegovina, Georgia, North Macedonia, Poland, Serbia +1 more
- A Study Evaluating the Presence and Concentration of BRIUMVI™ (Ublituximab) in Breast MilkRecruiting
Sponsor: TG Therapeutics, Inc.
Relapsing Multiple Sclerosis
United States
Sponsor: Novartis Pharmaceuticals
Tuberous Sclerosis Complex
United States, Australia, Belgium, Canada, Colombia +13 more
- Coupled Gentamicin-Lactobacillus Rhamnosus in NLUTDNot Yet Recruiting
Sponsor: Medstar Health Research Institute
Spinal Cord Injury · Neurogenic Bladder (NB) · Neurogenic Lower Urinary Tract Dysfunction · Multiple Sclerosis
United States
- A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, Radiological and Clinical Effects of Subcutaneous Ublituximab in Participants With Relapsing Multiple Sclerosis (RMS)Active Not Recruiting
Sponsor: TG Therapeutics, Inc.
Relapsing Multiple Sclerosis
Bosnia and Herzegovina, Bulgaria, Croatia, Czechia, Georgia +4 more
Sponsor: TG Therapeutics, Inc.
Multiple Sclerosis
United States
Sponsor: Novartis Pharmaceuticals
Multiple Sclerosis
United States
- An Extension Study of Ublituximab in Participants With Relapsing Multiple SclerosisActive Not Recruiting
Sponsor: TG Therapeutics, Inc.
Relapsing Multiple Sclerosis (RMS)
United States, Belarus, Croatia, Georgia, Poland +3 more
- Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of UblituximabRecruiting
Sponsor: TG Therapeutics, Inc.
Relapsing Multiple Sclerosis
United States, Poland
- MS-Related Disability Worsening and Thalamic Volume LossEnrolling By Invitation
Sponsor: Jung Diagnostics GmbH
Multiple Sclerosis, Relapsing-Remitting
Germany
Sponsor: TG Therapeutics, Inc.
Relapsing Multiple Sclerosis
Poland
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Lung Disease · Pneumothorax · Tuberous Sclerosis · Lymphangioleiomyomatosis
United States
Sponsor: Guangzhou Lupeng Pharmaceutical Company LTD.
Relapsing-remitting Multiple Sclerosis (RRMS)
China
Sponsor: Wayne State University
Multiple Sclerosis
United States
- A Study of Remibrutinib Using MR Imaging in Relapsing or Progressive MSNot Yet Recruiting
Sponsor: Moein Amin
Multiple Sclerosis (MS) - Relapsing-remitting · Multiple Sclerosis (MS) Secondary Progressive · Multiple Sclerosis (MS) Primary Progressive
United States
Sponsor: Novartis Pharmaceuticals
Scleroderma, Diffuse
United States, Argentina, Australia, Austria, Belgium +17 more
Sponsor: Celgene
Multiple Sclerosis Spasticity
United States, Australia, Canada, Czechia, Germany +2 more
Sponsor: Wayne State University
Multiple Sclerosis · Gait Disorders, Neurologic · Accidental Fall
United States
- A Study to Investigate the Efficacy of Fenebrutinib in Relapsing Multiple Sclerosis (RMS)Active Not Recruiting
Sponsor: Hoffmann-La Roche
Relapsing Multiple Sclerosis
United States, Bosnia and Herzegovina, Croatia, Czechia, Serbia +1 more
- Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-1)Active Not Recruiting
Sponsor: Novartis Pharmaceuticals
Relapsing Multiple Sclerosis
United States, Argentina, Austria, Belgium, Brazil +29 more
Sponsor: Leal Therapeutics, Inc
Amyotrophic Lateral Sclerosis
Germany, Italy, Netherlands, Sweden
Sponsor: Zenas BioPharma (USA), LLC
Secondary Progressive Multiple Sclerosis
United States, Croatia, Czechia, Lithuania, Poland +1 more
- High-Intensity Interval Training for Walking and Function Across Different Multiple Sclerosis Disability LevelsNot Yet Recruiting
Sponsor: Hacettepe University
MULTIPL SCLEROSİS
Turkey (Türkiye)
Sponsor: Zenas BioPharma (USA), LLC
Multiple Sclerosis (MS) Primary Progressive
United States, Bulgaria, Croatia, Czechia, Estonia +8 more
- Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-2)Active Not Recruiting
Sponsor: Novartis Pharmaceuticals
Relapsing Multiple Sclerosis
United States, Argentina, Brazil, Bulgaria, Canada +22 more
3,895 studies found